These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20371913)

  • 1. The integration of quantitative multi-modality imaging data into mathematical models of tumors.
    Atuegwu NC; Gore JC; Yankeelov TE
    Phys Med Biol; 2010 May; 55(9):2429-49. PubMed ID: 20371913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.
    Belhocine TZ; Blankenberg FG; Kartachova MS; Stitt LW; Vanderheyden JL; Hoebers FJ; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2083-97. PubMed ID: 26275392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor hypoxia imaging.
    Sun X; Niu G; Chan N; Shen B; Chen X
    Mol Imaging Biol; 2011 Jun; 13(3):399-410. PubMed ID: 20838906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography.
    van de Wiele C; Lahorte C; Vermeersch H; Loose D; Mervillie K; Steinmetz ND; Vanderheyden JL; Cuvelier CA; Slegers G; Dierck RA
    J Clin Oncol; 2003 Sep; 21(18):3483-7. PubMed ID: 12972524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab.
    Vangestel C; Van de Wiele C; Van Damme N; Staelens S; Pauwels P; Reutelingsperger CP; Peeters M
    J Nucl Med; 2011 Nov; 52(11):1786-94. PubMed ID: 22045708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer.
    Shah C; Miller TW; Wyatt SK; McKinley ET; Olivares MG; Sanchez V; Nolting DD; Buck JR; Zhao P; Ansari MS; Baldwin RM; Gore JC; Schiff R; Arteaga CL; Manning HC
    Clin Cancer Res; 2009 Jul; 15(14):4712-21. PubMed ID: 19584166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Feasibility of apoptosis-imaging agent 99mTc-HYNIC-annexin V in early assessment of chemotherapeutic effect on tumor models].
    Lan XL; Zhang YX; He Y; Sun X; An R; Gao ZR; Cao GX
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):737-40. PubMed ID: 19173800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The imaging of apoptosis with the radiolabelled annexin A5: a new tool in translational research.
    Belhocine TZ; Blankenberg FG
    Curr Clin Pharmacol; 2006 May; 1(2):129-37. PubMed ID: 18666365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic imaging end-points for the assessment of therapy response.
    Serkova NJ; Garg K; Bradshaw-Pierce EL
    Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):36-53. PubMed ID: 19149687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of treatment-induced apoptosis in normal structures: 99mTc-Hynic-rh-annexin V SPECT and CT image fusion.
    Kartachova MS; Valdés Olmos RA; Haas RL; Hoebers FJ; van den Brekel MW; van Zandwijk N; Herk Mv; Verheij M
    Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):893-9. PubMed ID: 16586080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental method and statistical analysis to fit tumor growth model using SPECT/CT imaging: a preclinical study.
    Hidrovo I; Dey J; Chesal ME; Shumilov D; Bhusal N; Mathis JM
    Quant Imaging Med Surg; 2017 Jun; 7(3):299-309. PubMed ID: 28811996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A realistic utilization of nanotechnology in molecular imaging and targeted radiotherapy of solid tumors.
    Patel V; Papineni RV; Gupta S; Stoyanova R; Ahmed MM
    Radiat Res; 2012 Apr; 177(4):483-95. PubMed ID: 22404738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-photon emission computed tomography tracers for predicting and monitoring cancer therapy.
    Cai J; Li F
    Curr Pharm Biotechnol; 2013; 14(7):693-707. PubMed ID: 24372237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging radiotherapy-induced apoptosis.
    Haimovitz-Friedman A; Yang TJ; Thin TH; Verheij M
    Radiat Res; 2012 Apr; 177(4):467-82. PubMed ID: 22348249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary in vivo evaluation of a novel 99mTc-labeled HYNIC-cys-annexin A5 as an apoptosis imaging agent.
    Fonge H; de Saint Hubert M; Vunckx K; Rattat D; Nuyts J; Bormans G; Ni Y; Reutelingsperger C; Verbruggen A
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3794-8. PubMed ID: 18524580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/CT imaging in cancer: current applications and future directions.
    Farwell MD; Pryma DA; Mankoff DA
    Cancer; 2014 Nov; 120(22):3433-45. PubMed ID: 24947987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Imaging of Apoptosis in Ischemia Reperfusion Injury With Radiolabeled Duramycin Targeting Phosphatidylethanolamine: Effective Target Uptake and Reduced Nontarget Organ Radiation Burden.
    Kawai H; Chaudhry F; Shekhar A; Petrov A; Nakahara T; Tanimoto T; Kim D; Chen J; Lebeche D; Blankenberg FG; Pak KY; Kolodgie FD; Virmani R; Sengupta P; Narula N; Hajjar RJ; Strauss HW; Narula J
    JACC Cardiovasc Imaging; 2018 Dec; 11(12):1823-1833. PubMed ID: 29454770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells.
    Vangestel C; Peeters M; Oltenfreiter R; D'Asseler Y; Staelens S; Van Steenkiste M; Philippé J; Kusters D; Reutelingsperger C; Van Damme N; Van de Wiele C
    Nucl Med Biol; 2010 Nov; 37(8):965-75. PubMed ID: 21055628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling tumor growth and treatment response based on quantitative imaging data.
    Yankeelov TE; Atuegwu NC; Deane NG; Gore JC
    Integr Biol (Camb); 2010 Aug; 2(7-8):338-45. PubMed ID: 20596581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.